The role of the carboxyl-terminal domain in rhodopsin transport was investigated using transgenic mice expressing a rhodopsin truncation mutant lacking the terminal 15 amino acids (S334ter). It was previously shown that S334ter translocates to the outer segment in the presence of endogenous rhodopsin. We now show that in the absence of endogenous rhodopsin S334ter mis-localizes to the plasma membrane and fails to reconstitute outer segment structures. Surprisingly, this mis-localization does not affect photoreceptor cell survival. These results provide further evidence on the important role of the COOH-terminal domain in rhodopsin trafficking and demonstrate an absolute requirement of this domain for correct vectorial transport of rhodopsin in rod photoreceptors. Ó
Introduction
The rod outer segment is an apical appendage of retinal rod photoreceptor cells that is specialized for transducing the light signal. This specialization is reflected by the extensive membranous disc stacks containing a near crystalline array of the light-capturing molecule, rhodopsin. In each rod outer segment there are approximately 5 Â 10 7 molecules of rhodopsin embedded within the discs and the plasma membrane. Rhodopsin comprises about 85% of the total protein in the rod outer segment and is localized almost exclusively to this structure. Transducin, phosphodiesterase and other proteins involved in phototransduction make up the majority of other proteins found in the outer segment. How the proteins involved in the signaling cascades are vectorially transported to this apical appendage of rod cells is not well understood.
There are over a hundred naturally occurring mutations in the rhodopsin gene that lead to autosomal dominant retinitis pigmentosa (Sohocki et al., 2001) . Some of these mutations are clustered around the highly conserved carboxyl-terminus of the rhodopsin molecule, e.g., P347L, P347S, P347R, V345M, Q344ter and two frameshift mutations fs341del (Horn et al., 1992) . Expression of some of these mutant proteins in COS-1 cells failed to reveal a biochemical defect (Kaushal & Khorana, 1994; Sung, Makino, Baylor, & Nathans, 1994; Sung, Sneider, Agarwal, Papermaster, & Nathans, 1991) . However, the fact that these mutations lead to retinal degeneration suggests that the carboxyl-terminal domain participates in an important physiological process distinct from phototransduction.
A role of the carboxyl-terminal domain in rhodopsin transport was first suggested by transgenic animal studies. Studies on transgenic mice expressing the Q344ter (Sung et al., 1994) , P347S (Li, Snyder, Olsson, & Dryja, 1996) and also transgenic rats expressing S334ter (Green, Menz, Lavail, & Flannery, 2000) in the presence of endogenous rhodopsin showed extensive mis-localization of rhodopsin to the plasma membrane and inner segments, where it is normally found in very low levels (Hicks & Barnstable, 1987; Hicks, Sparrow, & Barnstable, 1989; Nir & Papermaster, 1983) . Analysis using specific antibodies attributed this mis-localization exclusively to the mutant rhodopsins (Green et al., 2000; Li et al., 1996; Sung et al., 1994) . These observations suggest a defect in transport or retention of these mutant Vision Research 42 (2002) [417] [418] [419] [420] [421] [422] [423] [424] [425] [426] www.elsevier.com/locate/visres rhodopsin molecules in the outer segment. Nevertheless, in these studies the majority of the mutant rhodopsin molecules were correctly localized to the outer segment along with the endogenous rhodopsin. Therefore, it is uncertain whether the correct localization was due to cotransport of mutant rhodopsin molecules with normal endogenous rhodopsin in post-Golgi vesicles or whether there are other site(s) on the rhodopsin molecule distinct from the carboxyl-terminus domain that also contain(s) signals for transport. The in vivo role of the rhodopsin carboxyl-terminal domain has also been investigated using transgenic Xenopus laevis. Tam, Moritz, Hurd, and Papermaster (2000) reported that the terminal 44 amino acid cytoplasmic tail of rhodopsin redirects a GFP fusion protein exclusively to the rod outer segment, but GFP fusion proteins bearing the naturally occurring carboxylterminal mutations show GFP fluorescence at the outer segment, plasma membrane and the inner segment. This experiment established that the carboxyl-terminal domain contains a signal for transport to the outer segment, and that it alone is sufficient to target a heterologous protein to the correct location.
The role of the carboxyl-terminus in rhodopsin transport is also supported by recent in vitro evidence. Using a retinal cell-free system from frog retina, Deretic, Puleo-Scheppke, and Trippe (1996) demonstrated that an antibody against the rhodopsin COOH-terminus inhibits post-Golgi vesicle formation. A synthetic peptide corresponding to the carboxyl-terminus of rhodopsin also inhibited rhodopsin trafficking in post-Golgi vesicles, but peptides bearing the naturally occurring mutations, Q344ter, V345M, and P347S, did not show this inhibition (Deretic, Schmerl, Hargrave, Arendt, & McDowell, 1998) . Interestingly, the carboxyl-domain has been found to interact directly with Tctex-1, a dynein light chain (Tai, Chuang, Bode, Wolfrum, & Sung, 1999) . This finding provides a mechanistic model by which vesicles bearing rhodopsin molecules might be transported along the cytoskeleton towards the apical surface of rod photoreceptor cells.
Together, the in vivo and in vitro evidence clearly implicate the carboxyl-terminal domain in rhodopsin transport. However, since all of the in vivo experiments were performed in the presence of normal endogenous rhodopsin, and since all of the mutant rhodopsin molecules showed correct localization to the outer segments, the question remains whether the rhodopsin carboxylterminus plays a necessary and essential role. To address this question, we utilized a transgenic mouse line that expressed a rhodopsin truncation mutant that lacks the carboxyl-terminal 15 amino acid residues (S334ter). This transgene was introduced into the rhodopsin þ=þ, þ=À and À=À backgrounds to see whether rhodopsin transport can occur in the absence of the carboxyl-terminal domain and in the absence of endogenous rhodopsin.
Materials and methods

Generation of mouse lines
All mice were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. Transgenic mice expressing the S334ter form of rhodopsin (Chen, Makino, Peachey, Baylor, & Simon, 1995) or S338A rhodopsin Mendez, Krasnoperova, Lem, & Chen, 2000) , a control line, were mated with wildtype or rhodopsin knockout mice (rhoÀ=À) (Lem et al., 1999) to generate mice that expressed the transgene in the þ=þ, þ=À, or À=À endogenous rhodopsin genetic background.
All mice were born and raised in constant darkness to avoid retinal degeneration that might result from constitutive signaling caused by S334ter rhodopsin (Chen et al., 1995) .
Genotype analysis by PCR and Southern blotting
Mice were genotyped by PCR amplification and by Southern blot analysis. Genomic DNA was obtained from mouse-tail biopsy samples. The S334ter transgene was detected with primers Rho2 (5 0 TGGGAGAT-GACGACGCCTAA 3 0 ) and Rho3 (5 0 TGAGGGAG-GGGTACAGATCC 3 0 ), while S338A transgene was detected with primers mRH7.2 (5 0 GACGACGCCT-CGGCCACCGTG 3 0 ) and mRH5 (5 0 GGAGCCTG-CATGACCTCATCC 3 0 ). Transgenic mice bred to rhodopsin À=À mice were genotyped for the rodopsin locus. PCR was performed to detect the presence of the rod opsin null allele by using primers Rh1.1 (5 0 GTGCCTGGAGTTGCGCTGTG-GG 3 0 ) and Neo3 (5 0 CGGTGGATGTGGAATGTGT-GCGAG3 0 ). To distinguish between hemizygous ðþ=ÀÞ and homozygous ðÀ=ÀÞ rhodopsin knockout mice, Southern blot analysis was performed as described previously (Mendez, Krasnoperova et al., 2000) .
Determination of transgene expression level
Transgene expression level was determined in each line by quantitating the mutant-to-total rod opsin transcript ratio in transgene-positive mice in the rhodopsin þ=þ background at post-natal days 21-26 (P21-P26). Total RNA was isolated from individual retinas using the Trizol Reagent (Invitrogen Corp., Carlsbad, CA), and reverse transcription was performed to obtain single stranded cDNA. PCR amplification of cDNA was performed with primers mRh4 (5 0 GAGCTCTTCCA-TCTATAACCCGG 3 0 ) and mRh6 (5 0 GGCTGGA-GCCACCTGGCTG 3 0 ), which hybridize to identical sequences in the endogenous and transgenic loci and, therefore, amplify both with equal efficiency. Labeling of the PCR amplification product was carried out by addition of 10 lCi of a-32 P dCTP (3000 Ci/mmol) to the PCR reaction. PCR amplification products were precipitated, washed, resuspended in dH 2 O, and divided into two equal aliquots. One aliquot was digested with a restriction enzyme specific for the transgene (DdeI for S334ter; EaeI for S338A), and the other one was mock digested. Both aliquots were then loaded in a 12% BisTris polyacrylamide gel (Invitrogen Corp., Carlsbad, CA). The gel was dried, exposed and analyzed using the Storm 860 Phosphor Imager software (Amersham Pharmacia Biotech Inc., Piscataway, NJ).
Western blot analysis
Retinas were dissected out from dark-reared mice at post-natal days 21-26, under infrared illumination. Individual retinas were homogenized in homogenization buffer (80 mM Tris-HCl, pH 8.0; 4 mM MgCl 2 ; protease inhibitor cocktail (Boehringer Mannheim, Indianapolis, IN); and 0.5 mM phenylmethylsulfonyl fluoride) and incubated with DNase I (Boehringer Mannheim, Indianapolis, IN) for 30 min at room temperature. Laemmli buffer was added, and the indicated amounts (in retina equivalents) were separated in a 12% Tris-glycine polyacrylamide gel (Invitrogen Corp., Carlsbad, CA). Proteins were transferred onto a nitrocellulose membrane and incubated with mAb R2-12N (a generous gift from Paul Hargrave, University of Florida, Gainesville), and subsequently with goat anti-mouse IgG conjugated to horseradish peroxidase (Invitrogen Corp., Carlsbad, CA). Immunodetection was performed using the ECL system (Amersham Pharmacia Biotech Inc., Piscataway, CA).
Immunohistochemistry
Before enucleation, the superior pole for each mouse eye was cauterized for orientation. Eyecups from each transgenic line were prepared under infrared illumination at two time points: P21-P26 and P45-P50. The eyecups were incubated in fixative (4.0% paraformaldehyde, 0.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2) for 2 h at room temperature, and subsequently embedded in 30% sucrose in 0.1 M cacodylate buffer, pH 7.2 for 14-18 h at 4°C. The eyecups were hemisected, embedded in Tissue Tek â O.C.T. (Sakura Kinetek USA Inc., Torrance, CA), and quickly frozen using liquid N 2 . Using a Jung CM 3000 cryostat machine (Leica Inc., Deerfield, IL), the tissues were sectioned at 10 lm thickness. The sections were incubated for 1 h in blocking solution (2.0% bovine serum albumin (BSA), 0.3% Triton X-100, and 2% goat serum in phosphate buffer saline (PBS)), and incubated with either 1:25 dilution of R2-12N or 1:200 dilution of 1D4 for 1 h. Dilution buffer for primary antibody was 2.0% BSA, 2.0% goat serum in PBS. Sections were washed for 3 Â 5 min with plain dilution buffer and incubated for 30-45 min with 1:100 dilution of FITC-conjugated rabbit anti-mouse IgG (Vector Laboratories Inc., Burlingame, CA). Sections were washed for 3 Â 5 min with plain dilution buffer and for 2 Â 5 min with PBS. Sections were incubated for 5 min in 4.0% paraformaldehyde in PBS and washed for 2 Â 5 min with PBS. A tiny drop of Vectashield (Vector Laboratories Inc., Burlingame, CA) was placed on the sections, which then were cover slipped. Prepared cryostat sections were viewed and analyzed using a LSM 510 confocal microscope (Carl Zeiss Inc., Thornwood, NY).
Retinal morphometry
Before enucleation, the superior pole was cauterized for orientation. Eyecups from dark-reared mice were prepared under infrared light at two time points: P21-P26 and P45-P50. The eyecups were fixed overnight at 4°C in 1=2 Karnovsky buffer (2.5% glutaraldehyde, 2.0% paraformaldehyde in 0.1 M cacodylate buffer, pH 7.2) during which the lenses were removed after the first 15 minutes. The fixed eyecups were washed for 3 Â 10 min with 0.1 M cacodylate buffer, pH 7.2 and further fixed with 1% osmium tetraoxide in 0.1 M cacodylate buffer for 1.5-2.0 h at room temperature. Eyecups were washed 2 Â 10 min with 0.1 M cacodylate buffer, pH 7.2 and dehydrated in the following manner: 15 min each with 50%, 70%, 85%, and 95% ethanol; 3 Â 10 min 100% ethanol; and 2 Â 10 min 100% propylene oxide. Infiltration with epon (28.7% w/w epon 812, 14.4% w/w epon 826, 4.8% w/w epon 871, 46.4% w/w DDSA, 5.7% w/w NMA, and 3% BDMA) was performed as follows: overnight incubation with 1:1 epon: propylene oxide; overnight incubation with 2:1 epon: propylene oxide; and 6 h to overnight incubation with 100% epon. The eyecups were placed in molds filled with epon with the optic nerve in back and the superior pole pointing at 12 o'clock. The samples were baked for 3-4 days at 55°C.
Once hardened, the epon-embedded eyes were cut into 1 lm sections and stained with Richardson stain (0.5% methylene blue, 0.5% Azine II, and 0.5% borax in dH 2 O). Analysis by retinal morphometry was accomplished by counting the outer nuclear layer thickness in four distinct regions of the retina using the SlideBook 3.0 software (Intelligent Imaging Innovations, Inc., Denver, CO). Comparisons were made between mice expressing the S334ter rhodopsin and age-matched controls expressing no transgene in an equivalent endogenous rhodopsin background.
Results
Transgene expression levels and rod outer segment formation
Transgenic mice expressing S334ter (Fig. 1A) were bred with wildtype and rhodopsin knockout mice to obtain mice that expressed the S334ter transgene in the rhodopsin þ=þ, þ=À or À=À background (S334ter rhoþ=þ S334ter rhoþ=À or S334ter rhoÀ=À , respectively). A transgenic line expressing full-length rhodopsin bearing an Ala substitution, S338A, was chosen as a control based on its similar transgene mRNA expression levels as the S334ter line (Fig. 1B) . Since constitutive signaling through the phototransduction cascade has been implicated as a stimulus for photoreceptor cell death Chen, Simon, Matthes, Yasumura, & Lavail, 1999) and to avoid this condition caused by S334ter (Chen et al., 1995) , all mice were raised in constant darkness. Levels of transgene expression were determined by quantitating the amount of transgene transcript in each line at post-natal day 21-26. Rod opsin mRNA were amplified with primers that amplify both the endogenous and mutant rod opsin genes and, subsequently, was digested with restriction enzymes specific for the transgene (see Section 2). Transgene transcript in S334ter and S338A mice was determined to be $10% of the total in the rhodopsin þ=þ background. Although expressed at only 10% level, the S338A transgene was able to fully reconstitute the rod outer segments in the rhodopsin À=À background (Fig. 2 , compare B to A). Immunolocalization of rhodopsin using a monoclonal antibody recognizing the rhodopsin amino terminus (R2-12N) showed correct rhodopsin localization to the rod outer segments (Fig. 2, C and D) , similar to the wildtype control (Fig. 4A) . Therefore, S338A rhodopsin contains all the necessary elements for correct rhodopsin transport and localization. This observation is consistent with our previous finding that mutations at any of the Ser and Thr sites did not affect rhodopsin transport Mendez, Krasnoperova et al., 2000) . (Chen et al., 1995) . A transgenic line in which Ser338 was substituted to Ala was selected as the control line among a collection of rhodopsin mutants at the phosphorylation sites because it best matched S334ter level of expression. (B) Determination of the transgene-to-total rhodopsin transcript ratio, for S334ter (left panel) and S338A rhodopsin (right panel). Total rhodopsin transcript from transgenic retinas was amplified by RT-PCR and divided into two equal fractions. One was loaded directly (left lane), the other was digested with a restriction enzyme specific for the transgene and then loaded (right lane) into a 12% polyacrylamide gel. Transgene level of expression was determined to be 10% in both cases.
Transport of S334ter in the rhodopsin þ=þ and the rhodopsin À=À genetic background
Retinal morphology of mice expressing S334ter in the rhodopsin þ=þ, þ=À and À=À background was examined to see whether S334ter was able to contribute to rod outer segment formation. In contrast to S338A, rhodopsin À=À mice expressing Ser334ter transcript to 10% of the normal rhodopsin mRNA levels failed to form rod outer segments. As can be seen in Fig. 3 , the overall retinal morphology was not affected by the presence of S334ter transgene in any rhodopsin background. In the rhodopsin þ=þ or þ=À background, no differences were observed at the outer nuclear layer thickness or at the length of the rod outer segments between transgene-positive or negative control mice. In the rhodopsin À=À background, no outer segment formation was observed either in the absence or presence of the transgene. These results indicate that the rhodopsin carboxyl-terminus is required either directly or indirectly, for rod outer segment formation.
Expression of the truncated rhodopsin in S334ter rhoÀ=À mice was confirmed by immunofluorescence staining using monoclonal antibody R2-12N (Fig.  4) . In the rhodopsin À=À background where rod outer segments were absent, S334ter was mis-localized to the outer nuclear layer and the inner segments (Fig. 4C) . Similar mis-localization of S334ter in the rhodopsin þ=þ background was also suggested by the R2-12N staining pattern when compared to the wildtype control (Fig. 4, compare B to A) , with the signal in this case being additive from both S334ter and endogenous rhodopsins. Taken together, these results show that in the absence of the carboxyl-terminus and the absence of endogenous rhodopsin, S334ter rhodopsin molecules are randomly distributed in the rod cell.
Expression of the truncated rhodopsin protein in transgenic retinas was also confirmed by immunoblot analysis (Fig. 5) . Both the endogenous and the truncated S334ter rhodopsin molecules were detected in the S334ter rhoþ=þ sample, whereas only the truncated rhodopsin was present in the S334ter rhoÀ=À sample. As expected, the control S338A rhodopsin was indistinguishable in size from the wildtype rhodopsin. Despite their similar levels of transgene transcript, S334ter and S338A transgenic lines showed a strikingly different amount of mutant protein. As shown in Fig. 5 , the amount of rhodopsin in S334ter rhoÀ=À is dramatically lower than the amount of rhodopsin present in the S338A rhoÀ=À retina. This difference is likely due to a lack of rod outer segment disks in the S334ter rhoÀ=À retina, which precludes the accommodation and accumulation of transported rhodopsin molecules. In the absence of this structure, S334ter is likely targeted for degradation, resulting in lowered protein concentration.
Previous evidence indicate that some S334ter protein do traffic to the outer segment when endogenous rhodopsin is present. This observation is based on functional studies of S334ter in rod outer segments using single cell recordings and immunoblot analysis of rhodopsin from isolated rod outer segment preparations from transgenic mice expressing S334ter in the rhodopsin þ=þ background (Chen et al., 1995) . The result that mutant rhodopsin lacking the correct trafficking signal is able to transport to the rod outer segment in the presence of endogenous rhodopsin is consistent with published studies from other laboratories (Green et al., 2000; Li et al., 1996; Sung et al., 1994) . Together, these results indicate that mutant rhodopsins lacking the correct trafficking signal can be co-transported to the rod outer segment along with normal rhodopsin. The mislocalization and the lack of outer segment structures in the S334ter rhoÀ=À retinas demonstrate that the last 15 amino acids of the carboxyl-terminal domain contain a signal that is essential for rhodopsin transport.
Influence of S334ter on translocation of endogenous rhodopsin
Because endogenous rhodopsin does affect the translocation of S334ter, we explored the possibility that the reverse might also occur-that the presence of S334ter causes improper localization of endogenous rhodopsin. Retinal sections from S334ter rhoþ=þ and agematched non-transgenic control mice were stained with the monoclonal antibody 1D4 that recognized the carboxyl-terminal eight amino acids of rhodopsin (Hodges, Heaton, Parker, Molday, & Molday, 1988) , and is therefore specific for the endogenous rhodopsin (Fig. 6) . In wildtype retina rhodopsin was detected predominantly in the rod outer segment as expected. Light staining in the outer nuclear layer and a lack of staining in the inner segment indicate that rhodopsin is present in low amounts in the outer nuclear layer and largely absent in the inner segment (Fig. 6A) . In S334ter rhoþ=þ retinas strong staining was also seen in the rod outer segment, indicating that the majority of wildtype rhodopsin resides in this region. However, increased signal was seen in the outer nuclear layer and the inner segment when compared to the corresponding layers within the wildtype retina. This difference is highlighted in Fig. 6C and D, which show a higher magnification of the inner segment and outer segment layers. Here, rhodopsin reactivity at the inner segment is absent in the control retina (Fig. 6D) but apparent in the S334ter rhoþ=þ retina (Fig. 6C, arrowheads) . Together, these observations show that the presence of S334ter rhoþ=þ and a wildtype littermate control were compared by 12% SDS-PAGE after incubation with R2-12N mAb. Ser334ter rhodopsin is detected as a faster migrating species, given its 15 amino acids difference in size. More sample (3:2 Â 10 À4 retinal equivalents) was loaded from Ser334ter rhoÀ=À and S338A rhoÀ=À retinas in the same gel to compare rhodopsin transgene expression. Although transgenic lines with similar transcript expression levels were selected, there is a significant difference in terms of protein expression. This difference can be explained by the presence of a ROS layer in the S338A rhoÀ=À retina, and its absence in the S334ter rhoÀ=À retina. Fig. 4 . In the absence of endogenous rhodopsin, Ser334ter rhodopsin localizes to the outer nuclear layer and inner segments of photoreceptors. Immunolocalization of rhodopsin with mAb R2-12N in frozen retinal sections from 21-26 day-old wildtype (A), Ser334ter rhoþ=þ (B), and Ser334ter rhoÀ=À (C). R2-12N mAb recognizes residues 2-12 from the rhodopsin NH 2 -terminus, and therefore recognizes both the endogenous and transgenic rhodopsins. In the rhodopsin À=À background, S334ter fails to restore rod outer segments and is randomly distributed in the inner segments (IS) and outer nuclear layer (ONL). Note also the increased signal at the outer nuclear layer and inner segments in Ser334ter rhoþ=þ sections.
does affect normal trafficking of endogenous rhodopsin albeit to a relatively small degree.
S334ter mis-localization does not accelerate retinal degeneration
Outer nuclear thickness was measured at four different retinal regions across the span of the retina to compare the effect of S334ter mis-localization on photoreceptor cell survival in rhodopsin þ=þ and À=À backgrounds at two different ages (Fig. 7) . Measurements along the span of the retina were necessary because the rhodopsin promoter tends to exhibit a gradient of expression, with the superior pole of the retina showing a stronger expression pattern (Lem, Applebury, Falk, Flannery, & Simon, 1991) . Consistent with previous reports, retinas from rhodopsin À=À mice showed a progressive loss of photoreceptors as a function of age (compare the left panels with the right panels) (Humphries et al., 1997; Lem et al., 1999) . Measured outer nuclear layer thickness from mice expressing S334ter (filled bars) were the same as the corresponding rhodopsin þ=þ and À=À controls (white bars) along the span of the retina at both time points. These results demonstrate that rhodopsin mis-localization in itself is not a strong stimulus for photoreceptor cell death.
Discussion
Recent evidence from both in vitro and in vivo studies clearly demonstrates a direct role of rhodopsin's Fig. 7 . Ser334ter rhodopsin expression does not lead to cell death. Retinal outer nuclear layer (ONL) thickness was measured at 3.5 or 7 post-natal weeks in Ser334ter-expressing mice (black bars) and negative littermate controls (white bars) in the rhodopsin þ=þ (left panels) or À=À (right panels) genetic background. ONL thickness was measured at four different regions across a vertical section of the retina at or near the optic nerve (A-D, retinal diagram; S: superior, I: inferior). ONL thickness, expressed in lm, is the average of N ¼ 4-6 determinations per genotype per time point. Error bars represent the standard deviation. Fig. 6 . Endogenous rhodopsin mis-localizes to the inner segments in the presence of Ser334ter rhodopsin. Retinal sections were incubated with mAb 1D4, which recognizes rhodopsin's last eight carboxylterminal amino acids. MAb 1D4 does not recognize the Ser334ter truncated rhodopsin, and is therefore specific for the endogenous rhodopsin. A and C, S334ter rhoþ=þ ; B and D, wildtype. A and B, 40 Â magnification; C and D, 126 Â magnification. At each magnification, the same exposure time was used to take the pictures. Note the brighter signal in the outer nuclear layer (ONL) and rod inner segment (RIS) of the S334ter rhoþ=þ section (A) than of the wildtype control (B). Arrows in C point to photoreceptor inner segments that were immunoreactive to mAb 1D4. These results indicate that the presence of Ser334ter causes the mis-localization and/or retention of the endogenous rhodopsin in the ONL and IS to some extent.
carboxyl-terminus in its vectorial transport. However, the in vivo studies using transgenic animals do not address whether the carboxyl-terminal domain is absolutely required for transport because the expressed mutant rhodopsins do traffic to the outer segment in the presence of endogenous rhodopsin. Is correct transport of mutant rhodopsin due to trafficking signals residing in other domains distinct from the carboxyl-terminus? Or, are the mutant rhodopsin molecules co-transported with the endogenous wildtype rhodopsin? We expressed a carboxyl-terminal truncation mutant, S334ter, in the presence and absence of endogenous rhodopsin to address these questions.
Normal retinal architecture can be obtained by expressing a normal human rhodopsin transgene in the rhodopsin knockout mice (McNally et al., 1999) . Our result from S338A rhoÀ=À also established that 10% expression level of a rhodopsin phosphorylation site mutant transgene could restore normal retinal morphology in rhodopsin knockout mice. In contrast, S334ter failed to restore an outer segment in the rhodopsin À=À retina. Because rhodopsin also is required for outer segment formation from a structural point of view, the lack of outer segments in S334ter rhoÀ=À retinas might be due to its inability to maintain a stable disc structure. However, the COOH-domain is cytoplasmic and highly dynamic (Langen, Cai, Altenbach, Khorana, & Hubbell, 1999) and therefore is unlikely to contribute to structural stability. Rather, the lack of outer segment formation is most likely due to transport defects of S334ter resulting from the lack of the required trafficking signal. Thus, because rhodopsin-bearing vesicles are not properly transported to the apical surface, the outer segment fails to form. Recently, Tam et al. (2000) showed that the carboxyl-terminal 44 amino acid tail of rhodopsin, when fused to GFP, targets this fusion protein exclusively to the rod outer segment of transgenic frog retina. Our observation that S334ter rhodopsin fails to be transported, together with the carboxyl-terminus alone being sufficient to direct transport to the outer segment in the transgenic frog experiment, provides strong evidence that the carboxyl-terminal domain is necessary and sufficient for rhodopsin transport, and that there are no other trafficking signals residing in other domains that might serve redundant functions.
Why did the previous transgenic animal studies show the mutant rhodopsins to be localized to the outer segment? Our results suggest that the mutant rhodopsin molecules are co-transported with the endogenous rhodopsin. The post-Golgi vesicles containing rhodopsin are $300 nm in diameter (Deretic & Papermaster, 1991) , and it has been estimated that these vesicles could con- Rhodopsin is synthesized at the rough endoplasmic reticulum in the proximal inner segment of rod photoreceptors. In its journey to rod outer segments, where phototransduction takes place, it is first transported in post-Golgi membrane vesicles to the base of the connecting cilium. These 300 nm diameter vesicles contain up to 2000 rhodopsin molecules. Ser334ter and endogenous rhodopsin could therefore coexist in these rhodopsin-laden vesicles. Given that the rhodopsin carboxyl terminal domain has been involved in the sorting of these vesicles through the inner segment, co-localization of both rhodopsins within the same vesicles would explain both the presence of S334ter at rod outer segments in the rhodopsin þ=þ background, and the mis-localization of endogenous rhodopsin at the inner segments observed to some degree in the presence of the truncated rhodopsin.
tain $2000 rhodopsin molecules (Tam et al., 2000) . When wildtype rhodopsin is present in the majority or even at 50%, it can be expected that each vesicle will contain sufficient targeting signals from the wildtype protein. By this mechanism, the mutant proteins follow the bulk flow of normal rhodopsin to the outer segment (Fig. 8) . The same mechanism may also explain why S334ter affected localization of a small amount of endogenous rhodopsin to the inner segment and outer nuclear layer. It is possible that an over-threshold incorporation of the truncated rhodopsin in some vesicles might have led to failed transport of both S334ter and endogenous rhodopsins to these regions.
Failed rhodopsin transport may be a contributing factor to the pathogenesis of rod photoreceptors in retinitis pigmentosa or macular degeneration (Sung & Tai, 2000) . To see if this is the case, we performed careful morphometric measurements on the outer nuclear layer thickness to see whether S334ter expression affected photoreceptor cell survival in rhodopsin þ=þ and À=À retinas. Surprisingly, no difference in retinal thickness was observed between retinas expressing S334ter and the corresponding control retinas either at an early time point (three weeks), before noticeable thinning of the outer nuclear layer was observed in the rhodopsin À=À retina, or at a later time point (seven weeks), where the outer nuclear layer of the rhodopsin À=À retina was halved in thickness. This is in contrast to the finding of Green et al. (2000) who found that 10% expression level of the same murine S334ter construct in transgenic rats caused retinal degeneration both in lightreared and dark-reared animals. The discrepancy between the two different results may be due to a difference in animal model used or difference in environmental factors such as rearing conditions. Rhodopsin mutations at the carboxyl-terminus cause an autosomal dominantly inherited form of retinal degeneration in humans. Therefore, only one affected allele is sufficient to cause the disease phenotype, so it can be expected that in human disease, mutant rhodopsins will be expressed at 50% of the total rhodopsin population. The lack of effect by S334ter in our studies may be due to the relatively low expression level of this transgene. Doubling the gene dosage by breeding the S334ter transgene to homozygosity should bring the expression level to 20%, which is more in line with the expression levels in human disease. Future experiments will be conducted to see whether 20% expression of S334ter will have an effect on photoreceptor cell survival.
